Health ❯ Healthcare ❯ Pharmaceuticals ❯ Cancer Treatment

Clinical Trials

FDA Accepts ImmunityBio Filing to Expand ANKTIVA Use in Bladder Cancer

The FDA review sets a clear path for a potential label expansion pending a decision in early 2027.

Erasca Shares Plunge After Trial Death and Patent Challenge

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

AstraZeneca’s Imfinzi–Imjudo Regimen Improves Progression-Free Survival in Liver Cancer Trial

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

EU Regulators Back Libtayo as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development